expenses 0.84 (2.03) 2.86 (141.17) Net profit 7.37 (1.75) 9.12 (519.77) 2 Unit : MB For the period ended Change 31 March 2020 31 March 2019 MB % Earnings before interest, taxes, depreciation and amortization
on dissolution of Solvay Biochemicals (Taixing) Limited amounting to 89 MB from other comprehensive income to the profit of the year 2018. Summary of Performance For the year 2019, the Company and its
Consolidated Financial Statement (Unit: Million Baht) 2020 2019 YOY Million Baht % Sales and Services 366.78 1,329.58 (962.80) (72.41%) Gross Profit 87.30 131.58 (44.28) (33.65%) Other Income 87.83 18.63 69.20
or 11.5% from increase in net profit resulting to increase in unappropriated retained earnings. Please be informed accordingly, Yours sincerely, (Mr.Tanavijit Ankapipatchai) Director and Chief
issued and paid-up ordinary shares deducted by the number of treasury share GP = Gross Profit, EBITDA = Earnings before Interest, Tax, Depreciation & Amortization, EBIT = Earnings before Interest & Tax, NP
follows; Performance Highlights for Q1/2020 Net profit attributable to shareholders was 206.8 million baht, an increase of 62.3 million baht or 43.1% growth from the same quarter of last year. And the net
decrease in retained earnings of THB 210 million accounted for the 2019 interim dividend approved by the Board of Directors at the amount of THB 1,952 million (THB 0.65 per share), offsetting with profit for
summary as follows: Summary of the company’s operation result In the 1st quarter 2019, revenue from sale was increased from the same period of last year at 12.9% and having gross profit at 47.6%. Net profit
% and the return on equity (ROE) decreased from 2.28% to 0.68% and earnings per share (EPS) decreased from 1.22 Baht/share to 0.34 Baht/share. Gross Profit Margin decreased from 17.04% to 12.88%. The
; Unimit and its subsidiaries have contract revenues for Q2/2018 amount 129 Million Baht which is decrease of 113 Million Baht (47%) from Q2/2017 contract revenues. Q2/2018’s net profit of 7 Million Baht